YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.
de Nigris F, Zanella L, Cacciatore F, De Chiara A, Fazioli F, Chiappetta G, Apice G, Infante T, Monaco M, Rossiello R, et al. BMC Cancer. 2011 Nov 2; 11:472. Epub 2011 Nov 2.